News
Insulet drums up $85M from Cannacord Genuity
Mon, 01/14/2013 - 3:02pm
Insulet raises $85 million in a private placement with Cannaccord Genuity.
Insulet (NSDQ:PODD) inked a private placement deal with Canaccord Genuity for $85 million worth of its common stock.
The Bedford, Mass.-based insulin management company said it plans to use the fund for marketing its OmniPod insulin pump and product development,
the company said.
